Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by rbm0524on May 29, 2016 12:08pm
108 Views
Post# 24914077

RE:RE:RE:RE:RE:RE:RE:Financials Out

RE:RE:RE:RE:RE:RE:RE:Financials Out1 quarter is not a big enough sample to utilize sales as a % of available inventory as credible ratio in determining earning power. Firstly because as has been mentioned a couple times, they only had 1000 customers at end of q1 and importantly since it was first reporting period since achieving the sales license they would of had a steep learning curve in the sense of taking and processing orders, packaging and shipping etc. Likely wasn't an efficient process. With 3000 customers (and climbing) and with some efficiencies created from learning from initial mistakes in sales process, q2 results will be good to reference sales as a % of inventory as a credible indicator. I agree with tundra that next 3 months will be good opportunity to continue trading the stock. 
Bullboard Posts